GEHC
GE HealthCare Technologies Inc.NASDAQHealthcare$70.35-2.26%OpenMarket Cap: $32.06B
As of 2026-04-06
Valuation
P/E (TTM)
19.08
PEG
—
P/B
3.09
P/S
1.64
EV/EBITDA
10.49
DCF Value
$117.96
FCF Yield
4.7%
Div Yield
0.2%
Margins & Returns
Gross Margin
43.5%
Operating Margin
13.3%
Net Margin
8.6%
ROE
17.1%
ROA
7.5%
ROIC
8.5%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $4.67B | 54.3% | $664.0M | $184.0M | $0.38 | $0.04 |
| FY 2025 | $20.63B | 40.0% | $2.76B | $2.08B | $4.55 | $0.14 |
| Q3 2025 | $5.14B | 38.7% | $653.0M | $446.0M | $0.98 | $0.04 |
| Q2 2025 | $5.01B | 39.7% | $654.0M | $486.0M | $1.06 | $0.04 |
| Q1 2025 | $4.78B | 42.1% | $629.0M | $564.0M | $1.23 | $0.04 |
| Q4 2024 | $5.32B | 42.8% | $801.0M | $720.0M | $1.57 | $0.03 |
| FY 2024 | $19.67B | 41.7% | $2.63B | $1.99B | $4.34 | $0.12 |
| Q3 2024 | $4.86B | 41.7% | $676.0M | $471.0M | $1.02 | $0.03 |
| Q2 2024 | $4.84B | 41.4% | $608.0M | $428.0M | $0.93 | $0.03 |
| Q1 2024 | $4.65B | 40.9% | $540.0M | $374.0M | $0.81 | $0.03 |
| Q4 2023 | $5.21B | 41.4% | $689.0M | $403.0M | $0.88 | $0.03 |
| FY 2023 | $19.55B | 40.5% | $2.44B | $1.57B | $3.02 | $0.09 |